POP IN AND PLAY ASN LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (52/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
Corporate timeline (3 events)Click to expand
- 2025-05-06🏢Company incorporatedAs POP IN AND PLAY ASN LTD
- 2025-05-06➕WARD, Robin appointeddirector
- 2025-05-06📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.0 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Robin Ward Individual · British · DOB 12/1994 · age 32 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/05/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| RESOLVE MEDICOLEGAL LIMITED→ SC432222 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| REVOLUTIONEYES LTD→ SC805111 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| RIGHT THERE→ SC394447 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| ROTARY RESIDENTIAL AND CARE CENTRES→ SC160605 · est 1995 · no financials extracted | — | — | — | — | 30y | — | — |
| ROZ CARE LTD→ SC750753 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| S & G PATHOLOGY LTD→ SC648076 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| SAJID PHARMA LIMITED→ SC819090 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| SAMH SERVICES (SCOTLAND) LIMITED→ SC464846 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| SASIMG LTD→ SC731999 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| SATTAR OPHTHALMIC SERVICES LTD→ SC797927 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| SCOTCHILD CARE LIMITED→ SC625097 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| SCOTMED & OCCUPATIONAL HEALTH LIMITED→ SC425071 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.